Imagion Biosystems is a biotech company aiming to make a difference to the lives of cancer patients, with groundbreaking imaging techniques being trialled in Australian hospitals.
CEO Bob Proulx joins Sean Aylmer from San Diego to talk about Imagion's work, and why they chose to list on the ASX.

Afternoon Report | Market tumbles as oil surges
04:48

Rate hike next week; Middle East embassies shuttered; robotaxis sans steering wheels
17:13

Q+A: Investors lined up to buy gold. This is who they were buying from.
11:41